Could Daily Cranberry Consumption Contribute to Helicobacter pylori Suppression?

Sunday, Oct. 17, 2 - 2:30 p.m. Central

Helicobacter pylori bacterial infections are responsible for 90% of gastric ulcers, which when left untreated, increase the risk of developing gastric cancer. The American Cancer Society estimates that in 2021, 26,560 people in the US are expected to be diagnosed with gastric cancer, with 11,180 predicted deaths. Antibiotics are used to eradicate H. pylori, however, antibiotic resistance, potential negative side effects and access to antibiotics has hampered efforts to control the pathogen. Dietary interventions that contribute to suppressing a portion of infections could help reduce overall gastric ulcer incidence and potentially the number of gastric cancer cases. A growing body of clinical research, including a recent study in China suggests a role for cranberry, not as a substitute for antibiotics but as a dietary regimen to suppress some infections. Other research demonstrates that cranberry may help potentiate certain antibiotics when co-administered to eradicate H. pylori infections.

Presented by FNCE® Sponsor: The Cranberry Institute

Learning Objectives

  • Define the risks associated with H. pylori infection
  • Describe the clinical studies on cranberry intake and H. pylori suppression as well as the research that tested co-administration of cranberry with antibiotics for eradication
  • Explain the amount, type and frequency of daily cranberry juice consumption that has been used in research to achieve partial H. pylori suppression

Speaker

Amy Howell, PhD
Associate Research Scientist, Marucci Center for Blueberry Cranberry Research
Rutgers University
Amy Howell, PhD
Amy Howell, PhD